SUBSCRIBE
SUBSCRIBE
News   FDA

Novartis AG Says FDA Approves Menveo Vaccination in Children, Not Infants

January 31, 2011 | 
1 min read
Bloomberg -- U.S. regulators approved Novartis AG’s Menveo meningococcal vaccine for use in children from 2 years of age, though they requested more information on use of the shot in infants.
FDA Approvals
Food and Drug Administration (FDA) Novartis
MORE ON THIS TOPIC
Illustration of young woman standing in front of exit door
FDA
Interim CDER head Høeg is out days after Makary: report
May 15, 2026
 · 
1 min read
 · 
Gabrielle Masson
Illustration showing a downward graph trend
Regulatory
Future of Aardvark’s Prader-Willi drug in doubt as FDA slaps full hold on program
May 15, 2026
 · 
2 min read
 · 
Tristan Manalac
Lightbulb with tangled lines. Problem solving and brainstorming Idea concept. Vector illustration
Gene therapy
REGENXBIO slumps after serious side effects mar Duchenne gene therapy results
May 14, 2026
 · 
3 min read
 · 
Annalee Armstrong
Businessperson group is walking towards career success or a vacant promotion competition. isometric vector illustration.
FDA
Biotech leaders pitch Pazdur as next FDA chief
May 14, 2026
 · 
2 min read
 · 
Annalee Armstrong